CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings

Personalized medicine in breast cancer

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 147
Year: 2017
Present: پوستري
COI code: IPMCMED02_067
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Personalized medicine in breast cancer

  Anahita Ahmadsina - NourDanesh Institute of Higher Education, Meymeh, Isfahan, Iran
  Kamran Ghaedi - Cellular and Molecular Biology Division, Biology Department, Faculty of Sciences, University of Isfahan, Isfahan, Iran
Mansoureh Azadeh - Zistfanavari biotechnology institute, Isfahan, Iran
Atefeh Zamani - Zistfanavari biotechnology institute, Isfahan, Iran


Breast cancer is a complex disease caused by the progressive accumulation of multiple gene mutations combined with epigenetic dysregulation of critical genes and protein pathways. The discovery that mutations in the BRCA1 and BRCA2 genes increase the risk of breast cancers has radically transformed our understanding of the genetic basis of breast cancer, leading to improved management of high-risk women. Genomic changes differentiate tumors from normal tissues, permitting targeted treatments for several types of tumor and thereby extending survival and improving patients’ quality of life. According to the U.S. National Institutes of Health (NIH), personalized medicine is an emerging practice of medicine that uses an individual s genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease . The immediate challenge is to learn how to use the molecular characteristics of an individual and their tumor to improve detection and treatment, and ultimately to prevent the development of breast cancer. Personalized medicine builds on the Human Genome Project, which was forecasted to revolutionize disease risk prediction, with projected relative risks. The ultimate goal of personalized medicine is to furnish the proper treatment to the right person at the right time. Based on articles by google scholar, pubmed and science direct, we got these results. Personalized medicine is receiving a large amount of growing attention for its tremendous potential with myriad new opportunities. The ultimate promise of personalized medicine depends on the discovery of the personal genetic causes of disease.


Personalized medicine; Breast cancer; BRCA1; BRCA2; Treatment; Human Genome Project

Perma Link
COI code: IPMCMED02_067

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Ahmadsina, Anahita; Kamran Ghaedi; Mansoureh Azadeh & Atefeh Zamani, 2017, Personalized medicine in breast cancer, 2nd International Personalized Medical Congress, تهران, دانشگاه علوم پزشكي بقيه الله(عج), the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Ahmadsina, Anahita; Kamran Ghaedi; Mansoureh Azadeh & Atefeh Zamani, 2017)
Second and more: (Ahmadsina; Ghaedi; Azadeh & Zamani, 2017)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)


The University/Research Center Information:
Type: Nonprofit Institute
Paper No.: 82
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

The Above articles are recently indexed in the related subjects

Iran Scientific Advertisment Netword

Share this paper


COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.